Evidence map›Paper›PMID 20545847›Full record

ArticleMolecular microbiology2010

The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis.

Ashraf S Ibrahim, Teclegiorgis Gebremariam, Lin Lin, Guanpingsheng Luo, Mohamed I Husseiny, Christopher D Skory, Yue Fu, Samuel W French, John E Edwards, Brad Spellberg

Open access · greenAbstract read
In one paragraph

Article in Molecular microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 155 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Future Prospects and Challenges in Mucormycosis Research.Journal of fungi (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Review
  10. Review
  11. Mucormycosis: A Rare disease to Notifiable Disease.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Review
  12. Molecular mechanisms that govern infection and antifungal resistance in Mucorales.Microbiology and molecular biology reviews : MMBR · 2024
    Review
  13. Review
  14. IntegratingCurrent research in microbial sciences · 2024
    Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Journal of fungi (Basel, Switzerland) · 2023
    Review
  20. Mucormycosis in 2023: an update on pathogenesis and management.Frontiers in cellular and infection microbiology · 2023
    Review

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Ashraf S IbrahimDivision of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-University of California Los Angeles (UCLA) Medical Center, Torrance, CA, USA. ibrahim@labiomed.org
Teclegiorgis Gebremariam
Lin Lin
Guanpingsheng Luo
Mohamed I Husseiny
Christopher D Skory
Yue Fu
Samuel W French
John E Edwards
Brad Spellberg
University of California, Los Angeles · USThe Lundquist Institute · USBiomed Research Institute · USNational Center for Agricultural Utilization Research · USUCLA Medical Center · US

Funding

Novel Toxins and Receptors in Mucormycosis Pathogenesis and TreatmentR01AI063503 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI IBRAHIM, ASHRAF S. · 2006 to 2025
$7.3M
An Ftr1 vaccine to abrogate mucormycosisR21AI082414 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI IBRAHIM, ASHRAF S. · 2010 to 2011
$386k
NIAID NIH HHS R01 AI063503NIAID NIH HHS R21 AI082414
6 · The paper itself

Abstract

Rhizopus oryzae is the most common cause of mucormycosis, an angioinvasive fungal infection that causes more then 50% mortality rate despite first-line therapy. Clinical and animal model data clearly demonstrate that the presence of elevated available serum iron predisposes the host to mucormycosis. The high affinity iron permease gene (FTR1) is required for R. oryzae iron transport in iron-depleted environments. Here we demonstrate that FTR1 is required for full virulence of R. oryzae in mice. We show that FTR1 is expressed during infection in diabetic ketoacidosis (DKA) mice. In addition, we disrupted FTR1 by double cross-over homologous recombination, but multinucleated R. oryzae could not be forced to segregate to a homokaryotic null allele. Nevertheless, a reduction of the relative copy number of FTR1 and inhibition of FTR1 expression by RNAi compromised the ability of R. oryzae to acquire iron in vitro and reduced its virulence in DKA mice. Importantly, passive immunization with anti-Ftr1p immune sera protected DKA mice from infection with R. oryzae. Thus, FTR1 is a virulence factor for R. oryzae, and anti-Ftr1p passive immunotherapy deserves further evaluation as a strategy to improve outcomes of deadly mucormycosis.

Indexed as

AnimalsDiabetic KetoacidosisFungal ProteinsHumansIronMaleMembrane Transport ProteinsMiceMice, Inbred BALB CMucormycosisProtein BindingRhizopusVirulence FactorsFungal ProteinsIronMembrane Transport ProteinsVirulence Factors

Identifiers

PMID20545847
PMCPMC2909342
OpenAlexW1479931945

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.